Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Júlia Ariana de Souza GomesDanielle Silveira Macêdo

Abstract

Activation of the brain angiotensin II type 1 receptor (AT1R) triggers pro-oxidant and pro-inflammatory mechanisms which are involved in the neurobiology of bipolar disorder (BD). Candesartan (CDS) is an AT1 receptor antagonist with potential neuroprotective properties. Herein we investigated CDS effects against oxidative, neurotrophic inflammatory and cognitive effects of amphetamine (AMPH)-induced mania. In the reversal protocol adult mice were given AMPH 2 mg/kg i.p. or saline and between days 8 and 14 received CDS 0.1, 0.3 or 1 mg/kg orally, lithium (Li) 47.5 mg/kg i.p., or saline. In the prevention treatment, mice were pretreated with CDS, Li or saline prior to AMPH. Locomotor activity and working memory performance were assessed. Glutathione (GSH), thiobarbituric acid-reactive substance (TBARS) and TNF-α levels were evaluated in the hippocampus (HC) and cerebellar vermis (CV). Brain-derived neurotrophic factor (BDNF) and glycogen synthase kinase 3-beta (GSK-3beta) levels were measured in the HC. CDS and Li prevented and reversed the AMPH-induced increases in locomotor activity. Only CDS prevented and reversed AMPH-induced working memory deficits. CDS prevented AMPH-induced alterations in GSH (HC and CV), TBARS (HC and CV)...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
May 1, 1973·Animal Behaviour·J Archer
Mar 21, 2001·Bipolar Disorders·H S Hopkins, A J Gelenberg
Sep 7, 2002·Circulation Research·Puvi N SeshiahKathy K Griendling
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·M J McKinleyS Y Chai
May 29, 2003·British Journal of Pharmacology·Shereeni J Veerasingham, Mohan K Raizada
Feb 3, 2004·The American Journal of Psychiatry·Anabel Martínez-AránManel Salamero
Apr 20, 2004·European Journal of Pharmacology·Carolyn A Bondy, Clara M Cheng
Sep 24, 2004·Bipolar Disorders·Amy M KilbourneGretchen L Haas
Apr 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Todd D Gould, Husseini K Manji
Jan 13, 2006·Journal of Psychopharmacology·Haim Einat
Feb 8, 2006·Life Sciences·Benício N FreyFlávio Kapczinski
Apr 17, 2007·Journal of Affective Disorders·Yong-Ku KimSun-Hwa Park
Jun 1, 2007·The Journal of Pharmacology and Experimental Therapeutics·Keun-Hwa JungJae-Kyu Roh
Oct 19, 2007·Acta Psychiatrica Scandinavica. Supplementum·M BerkT Norman
Sep 6, 2007·The Cerebellum·Jeremy D SchmahmannJanet C Sherman
Mar 5, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Elisa Brietzke, Flávio Kapczinski
Jun 10, 2008·Journal of Affective Disorders·Ana C AndreazzaLakshmi N Yatham
Jun 19, 2008·The Journal of Pharmacology and Experimental Therapeutics·Wieslaw KozakSusan C Fagan
May 29, 2009·Journal of Psychiatric Research·Gislaine S de OliveiraFlavio Kapczinski
Jul 7, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Janusz K RybakowskiAlina Borkowska
Mar 26, 2010·Journal of Psychiatric Research·Samira S ValvassoriJoão Quevedo
Nov 3, 2010·Bipolar Disorders·Xiaohong LiXiaohua Li
Dec 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julius BenickyJuan M Saavedra
Mar 18, 2011·British Journal of Pharmacology·Jared W YoungMark A Geyer
Nov 11, 2011·CNS Neuroscience & Therapeutics·Rasmus W Licht
Jul 4, 2012·Journal of Affective Disorders·Sinan GuloksuzJim van Os
Aug 18, 2012·Bipolar Disorders·Danielle S MacêdoAndré F Carvalho
Oct 17, 2012·Psychiatry and Clinical Neurosciences·Olivia M DeanMichael Berk
Dec 26, 2012·Medical Hypotheses·Ana Isabelle de Góis QueirozDanielle Silveira Macêdo
Dec 26, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Walther BildAlin Ciobica
Jan 22, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Danielle S MacêdoAndré F Carvalho
May 24, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shusuke YagiMasataka Sata

❮ Previous
Next ❯

Citations

Jul 30, 2017·The Australian and New Zealand Journal of Psychiatry·Daniel J BrownsteinBrisa S Fernandes
Jun 30, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Srisaiyini KidnapillaiKen Walder
Mar 16, 2019·Bipolar Disorders·Lars V KessingPer K Andersen
Dec 24, 2019·Protein and Peptide Letters·Satyajit MohiteAntonio L Teixeira
Aug 2, 2017·BMC Medicine·João VianBrisa S Fernandes
Nov 17, 2020·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Adriano José Maia Chaves FilhoDanielle S Macedo
May 14, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Germana Silva VasconcelosDanielle S Macedo
May 21, 2021·Frontiers in Pharmacology·Osvaldo M BasmadjianClaudia Bregonzio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.